Keep up to date with the latest news and events
April 29, 2023
Launch of ALAN Patient Preference Study
Read more
April 14, 2023
Q2 2023: Additional information and data in acute leukemia
Read more
March 30, 2023
Webinar: Latest advances in treatment of ALL and what it means for patients ?
Read more
March 21, 2023
Webinar: Latest advances in treatment of AML and what it means for patients
Read more
March 15, 2023
Q1 2023: Additional information and data in acute leukemia
Read more
March 14, 2023
Upcoming webinar: The importance of MRD in acute leukemia
Read more
March 14, 2023
Upcoming webinar: How is the risk classification in AML driving treatment intensity ?
Read more
March 13, 2023
Q1 2023 Newsletter
Read more
February 28, 2023
WECAN statement concerning recent reports about ECPC and the potential impact on EU research projects
Read more
February 20, 2023
ALAN Global Summit 5th-7th May 2023
Read more
February 9, 2023
T2EVOLVE-QUALITOP
Read more
December 13, 2022
Q4 2022 Newsletter
Read more